News and Trends 8 Apr 2022 Epidarex Backs UK Startup Developing Emerging Anti-Inflammatory Drugs …pathway metabolites,” said Damian Mole, Kynos’ CEO. “This is important for regulating immune cell activity, but it also prevents metabolic injury to cells and tissues.” In 2019, GSK chose to… April 8, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Sep 2022 Ilya Pharma enrols first patient in diabetic foot ulcer study …foot ulcers. Additional endpoints include reduction in wound infections, antibiotic saving effects, analyses of the mechanism of action and the impact of ILP100-Topical on significant clinical events, during treatment and… September 28, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Sep 2017 Tiziana‘s Antibody Formulation Enters Phase IIa Trial for Liver Disease Treatment …the liver, and potential complications such as cirrhosis, liver cancer, and liver failure. Foralumab binds to and inhibits CD3, which prevents cytotoxic and helper T cell activation. Inhibition of their… September 6, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Podcast 23 Feb 2024 Precision neuromedicine: A new dawn for neurological disorders …co-founder and CSO David Bredt. Neurology received the second-most new drug approvals from the FDA in 2023 among all disease areas. The year ended with two multi-billion M&A events: BMS’s… February 23, 2024 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2017 A Breath of Fresh Air for Biotechs Working on Cystic Fibrosis Therapies? …Cystic fibrosis is a severe genetic disease affecting the lungs, for which there is currently no cure. It is caused by a malfunctioning chloride channel, CFTR, which prevents the secretion… December 14, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Opinion 21 Jun 2021 A Window to the Past: Is the Biotech Investment Boom Going to Last? …a confluence of events fired up biotech investment again. Just as recombinant DNA technology and monoclonal antibodies turbocharged the nascent biotech sector in the 1980s, cheap high-throughput sequencing and the… June 21, 2021 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2022 EMPA-KIDNEY trial meets primary endpoint in trial for drug to treat chronic kidney disease …however the power to detect this was limited by the number of events observed. Reduction in the risk of these endpoints is consistent with the totality of the evidence from other… November 4, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 7 Feb 2023 Certa scleroderma study shows improvement in more than 60% of patients …demonstrated statistically significant improvements over 12 weeks of treatment when compared to placebo for pain, breathing problems, finger ulcers and overall disease activity. No adverse events Global physician assessments of… February 7, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 Feb 2023 Newron reports ‘striking’ schizophrenia study results …to the current antipsychotic medication continued to be well tolerated, only two patients discontinued for adverse events (flu-like symptoms and headache) after one year of treatment. Better than expected results… February 16, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Mar 2025 Seven biotech companies keeping Taiwan dynamic in 2025 …fat rating scale (CR-AFRS), with nearly 60% achieving this result after just one treatment. The study also demonstrated a favorable safety and tolerability profile, with no drug-related serious adverse events… March 5, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2022 New biotech company aims to bridge gap between stem cell research and athletic injuries …Given the autologous nature of Celltex-produced stem cells, there have been no severe adverse events when these stem cells have been reintroduced into the individuals from whom the small, one-time… October 5, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 14 May 2019 First Potential Gene Therapy for Hemophilia B Restores Blood Clotting in Phase II …to stop taking FIX replacement therapy used to control bleeds, and experienced no serious adverse events. These preliminary results are good news for uniQure, as they prove the company made… May 14, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email